The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months
User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.
Study among fisherfolk, sex workers, truck drivers and others at higher risk of HIV finds many are willing to try PrEP – but only for around six weeks.
The proportion of South Africans ever testing for HIV increased from 30% to 75% between 2005 and 2017 – but differences remain in who is getting tested
We have launched a new mobile app made in collaboration with community health workers in Southern Africa. Find out all you need to know about Boost!
Mobile testing and door-to-door approaches result in a 25% increase in status awareness, with particularly significant gains in diagnosing HIV-positive young people and men.
An evaluation of Zvandiri, a teen-led programme for HIV-positive adolescents in Zimbabwe, finds it significantly improves treatment outcomes and boosts self-esteem.